Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

32% lower incidence of hypoglycemia and 46% lower incidence of hyperglycemia with ketosis at month 6 were observed with Glargine 300 in the first head to head study comparing newer generation basal insulin analog vs Glargine 100 in pediatric diabetic pts.